P. Mcmanus

发表

Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia.

D. Birkett, P. Mcmanus, J. Marley, 1998, British journal of clinical pharmacology.

Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis

I. Hickie, P. Mitchell, A. Mant, 2003, BMJ : British Medical Journal.

Impact of increasing the re‐supply interval on the seasonality of subsidised prescription use in Australia

N. Donnelly, P. Mcmanus, J. Dudley, 2000, Australian and New Zealand journal of public health.

A cost-effectiveness approach to drug subsidy and pricing in Australia.

A. Mitchell, D. Birkett, P. Mcmanus, 2001, Health affairs.

Making new choices about antidepressants in Australia: the long view 1975–2002

I. Hickie, P. Mitchell, A. Mant, 2004, The Medical journal of Australia.

Prescription Drug Utilization Following Patient Co‐Payment Changes in Australia

J. Primrose, N. Donnelly, D. Henry, 1996, Pharmacoepidemiology and drug safety.

Recent trends in the use of antidepressant drugs in Australia, 1990–1998

P. Mitchell, A. Mant, J. Marley, 2000, The Medical journal of Australia.

Recent trends in the use of antiasthmatic drugs

P. Mcmanus, D. Birkett, 1993, The Medical journal of Australia.

Changes in Fatalities Due to Overdose of Anxiolytic and Sedative Drugs in the UK (1983–1999)

N. Buckley, P. Mcmanus, 2004, Drug safety.

Pattern of non‐steroidal anti‐inflammatory drug use in Australia 1990–1994 A report from the Drug Utilization Sub‐Committee of the Pharmaceutical Benefits Advisory Committee

R. Day, J. Primrose, D. Henry, 1996, The Medical journal of Australia.

Antibiotic use in the Australian community, 1990‐1995

J. Primrose, A. Mant, S. Whicker, 1997, The Medical journal of Australia.

Discontinuation rates for use of statins are high

J. Simons, L. Simons, P. Mcmanus, 2000, British medical journal.

Can the Fatal Toxicity of Antidepressant Drugs be Predicted with Pharmacological and Toxicological Data?

N. Buckley, P. Mcmanus, 1998, Drug safety.

Fatal toxicity of drugs used in the treatment of psychotic illnesses

N. Buckley, P. Mcmanus, 1998, British Journal of Psychiatry.

Benzodiazepine utilisation in Australia: report from a new pharmacoepidemiological database.

A. Mant, S. Whicker, D. Birkett, 2010, Australian journal of public health.

Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data

N. Buckley, P. Mcmanus, 2002, BMJ : British Medical Journal.

Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia

D. Birkett, P. Mcmanus, J. Dudley, 2001, Pharmacoepidemiology and drug safety.

Length of Therapy with Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants in Australia

P. Mitchell, A. Mant, P. Mcmanus, 2004, The Australian and New Zealand journal of psychiatry.

Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia.

P. Mitchell, A. Mant, P. Mcmanus, 2004, Australian and New Zealand journal of psychiatry (Print).

Cardiovascular drugs in Australian hospitals

P. Mcmanus, 1992, The Medical journal of Australia.

Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?

A. Mant, P. Mitchell, D. Birkett, 2001, British journal of clinical pharmacology.

Use of Antidepressants by General Practitioners and Psychiatrists in Australia

P. Mitchell, H. Britt, A. Mant, 2003, The Australian and New Zealand journal of psychiatry.

Development of an Australian drug utilisation database: a report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee.

J. Primrose, D. Birkett, P. Mcmanus, 1993, PharmacoEconomics.

Examining the adequacy of quantities available for subsidized antidepressant prescriptions in Australia

A. Mant, M. Hemming, P. Mcmanus, 1999, Pharmacoepidemiology and drug safety.